DI CESARE MANNELLI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 26.379
EU - Europa 24.382
AS - Asia 11.802
SA - Sud America 2.051
Continente sconosciuto - Info sul continente non disponibili 649
AF - Africa 339
OC - Oceania 163
Totale 65.765
Nazione #
US - Stati Uniti d'America 25.863
PL - Polonia 10.507
RU - Federazione Russa 5.350
IT - Italia 3.961
SG - Singapore 3.146
CN - Cina 2.680
HK - Hong Kong 1.894
BR - Brasile 1.674
VN - Vietnam 1.454
IE - Irlanda 1.276
KR - Corea 893
SE - Svezia 839
FI - Finlandia 580
FR - Francia 508
DE - Germania 446
IN - India 396
GB - Regno Unito 342
CA - Canada 323
ID - Indonesia 277
BD - Bangladesh 268
AR - Argentina 157
JP - Giappone 156
AU - Australia 155
JO - Giordania 141
UA - Ucraina 120
NL - Olanda 100
TR - Turchia 90
IQ - Iraq 89
CI - Costa d'Avorio 85
MX - Messico 85
ES - Italia 81
ZA - Sudafrica 69
CH - Svizzera 59
EC - Ecuador 57
BE - Belgio 52
PK - Pakistan 40
NG - Nigeria 36
CO - Colombia 35
MA - Marocco 35
PY - Paraguay 32
VE - Venezuela 29
RO - Romania 28
UZ - Uzbekistan 28
PE - Perù 27
SA - Arabia Saudita 27
AE - Emirati Arabi Uniti 26
CL - Cile 24
EG - Egitto 23
TH - Thailandia 23
TN - Tunisia 22
JM - Giamaica 21
IR - Iran 20
CR - Costa Rica 19
PH - Filippine 19
IL - Israele 18
AL - Albania 15
AZ - Azerbaigian 15
DZ - Algeria 14
AT - Austria 13
LB - Libano 13
PT - Portogallo 13
KE - Kenya 12
MY - Malesia 12
BG - Bulgaria 11
HN - Honduras 11
LT - Lituania 11
NP - Nepal 11
CZ - Repubblica Ceca 10
KZ - Kazakistan 10
DO - Repubblica Dominicana 9
SK - Slovacchia (Repubblica Slovacca) 9
TW - Taiwan 9
BJ - Benin 8
GT - Guatemala 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
UY - Uruguay 8
BO - Bolivia 7
DK - Danimarca 7
ET - Etiopia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
GR - Grecia 6
KG - Kirghizistan 6
LV - Lettonia 6
RS - Serbia 6
BH - Bahrain 5
NO - Norvegia 5
OM - Oman 5
QA - Qatar 5
AM - Armenia 4
BB - Barbados 4
HR - Croazia 4
HU - Ungheria 4
KW - Kuwait 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SC - Seychelles 4
AO - Angola 3
CG - Congo 3
Totale 65.060
Città #
Warsaw 10.495
Santa Clara 5.160
Ashburn 3.369
Fairfield 2.212
Singapore 2.210
Hong Kong 1.607
Dublin 1.267
Woodbridge 1.032
Chandler 1.010
Seattle 904
San Jose 903
Seoul 863
Cambridge 829
Houston 792
Wilmington 739
Milan 689
Beijing 626
Florence 544
Council Bluffs 462
Altamura 436
Lawrence 430
Ho Chi Minh City 419
Ann Arbor 405
Hefei 387
The Dalles 370
Princeton 363
Los Angeles 356
Rome 347
Helsinki 305
Lauterbourg 300
Hanoi 285
Buffalo 277
Moscow 277
New York 224
Mumbai 220
Dallas 207
Jakarta 206
Dong Ket 198
Boston 193
Medford 193
San Diego 157
Munich 152
Boardman 142
Jacksonville 142
Shanghai 142
Melbourne 139
Clifton 132
São Paulo 129
Tokyo 127
Phoenix 116
Paris 109
Kent 108
Chicago 94
Abidjan 85
Naples 84
London 81
Turin 79
Orem 78
Frankfurt am Main 77
Falls Church 75
Toronto 70
Philadelphia 69
Bologna 68
Turku 67
Redondo Beach 62
Guangzhou 58
Rio de Janeiro 57
Figino 56
Norwalk 55
Da Nang 53
Tianjin 53
Haiphong 52
Miano 50
Montreal 50
Lappeenranta 49
Brooklyn 42
Brussels 42
Bern 40
Hillsboro 38
Palermo 38
Barcelona 37
Baghdad 36
Chennai 36
Bari 35
Genoa 35
Siena 35
Brasília 31
Amsterdam 30
Biên Hòa 30
San Francisco 30
Atlanta 28
Izmir 28
North Bergen 28
Redwood City 28
Abuja 27
Curitiba 27
Salt Lake City 26
Amman 25
Padua 25
Venice 25
Totale 46.030
Nome #
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 401
Acute effect of Capparis spinosa root extracts on rat articular pain 385
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 376
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 372
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 364
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 361
Synthesis of novel cognition enhancer with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at gamma-aminobutyric acid type A (GABAA) receptor. 361
Gc-protein derived macrophage activating factor (GcMAF) counteracts the neuronal damage induced by oxaliplatin 356
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 356
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 353
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 345
Local anaesthetic activity of beta-caryophyllene. 344
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 338
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 338
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 338
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 335
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 333
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 332
Delay of morphine tolerance by palmitoylethanolamide 330
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 329
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 327
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 325
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 324
The pharmacological basis of opioids 323
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 320
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 319
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 318
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 316
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 316
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 315
Selenium and zinc: Two key players against cadmium-induced neuronal toxicity. 311
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 308
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 307
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 304
Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations 304
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 300
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 300
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 300
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 298
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 297
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 293
Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin 292
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide 292
Astragalus membranaceus and oxaliplatin-induced neuropathy: pain relief and prevention of nervous tissue modifications. 290
Brain activity of thioctic Acid enantiomers: in vitro and in vivo studies in an animal model of cerebrovascular injury 290
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 290
Therapeutic Effects of the Superoxide Dismutase Mimetic Compound Mn(II)Me2DO2A on Experimental Articular Pain in Rats. 289
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 289
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 289
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 288
Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats 285
PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures 284
Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury. 282
Low dose native type II collagen prevents pain in a rat osteoarthritis model 281
Photobiomodulation therapy by NIR laser in persistent pain: an analytical study in the rat 281
Neuropathy-induced apoptosis: Protective effect of physostigmine 281
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 279
Effects of a water extract of Lepidium meyenii root in different models of persistent pain in rats 279
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus 279
Pretreatment with relaxin does not restore no-mediated modulation of calcium signal in coronary endothelial cells isolated from spontaneously hypertensive rats 278
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 277
Using palmitoylethanolamide in combination with opioids 274
RELAXANT EFFECT OF A WATER SOLUBLE CARBON MONOXIDE-RELEASING MOLECULE (CORM-3) ON SPONTANEOUSLY HYPERTENSIVE RAT AORTAS 271
Palmitoylthanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-apha-mediated mechanism. 270
GLUTAMATERGIC SYSTEM MODULATORS AS AGENTS IN PREVENTION AND MANAGEMENT OF CHEMOTHERAPY- INDUCED POLYNEUROPATHY 270
OXALIPLATIN-INDUCED BLOOD BRAIN BARRIER LOOSENING: A NEW POINT OF VIEW ON CHEMOTHERAPY-INDUCED NEUROTOXICITY 270
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines 269
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues 268
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced anti-proliferative profiles. 266
Development of ligands at gamma aminobutyrric acid type A (GABAA) receptor subtype as new agent for pain relief. 266
TREATMENT WITH ACETYL-L-CARNITINE EXERTS A NEUROPROTECTIVE EFFECT IN THE SCIATIC NERVE FOLLOWING LOOSE LIGATION: A FUNCTIONAL AND MICROANATOMICAL STUDY 266
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 261
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 260
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 258
Effects of Cadmium on ZO-1 Tight Junction Integrity of the Blood Brain Barrier. 257
Pain relieving and protective effects of Astragalus hydroalcoholic extract in rat arthritis models 256
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 256
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2 S release in vivo. 254
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 253
Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy 253
Anticancer properties of erucin, an H2 S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1). 252
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 251
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy. 246
Erucin exhibits vasorelaxing effects and antihypertensive activity by H2 S-releasing properties 245
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 242
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) 237
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 236
Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology 236
Cannabidiol protects dopaminergic neuronal cells from cadmium 236
Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis 235
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain 234
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice . 232
Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1 230
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 230
Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels 229
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation 228
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief 228
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 228
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 228
Pain relieving effect of-NSAIDS-CAIs hybrid molecules: Systemic and intra-articular treatments against rheumatoid arthritis 226
Totale 28.974
Categoria #
all - tutte 173.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.297 0 165 210 117 74 144 91 187 188 189 310 622
2022/20235.305 540 1.178 254 264 334 929 768 287 469 38 153 91
2023/20242.021 90 218 349 97 138 281 97 355 51 137 138 70
2024/202515.786 527 1.696 1.090 2.242 4.320 2.024 468 820 925 450 613 611
2025/202619.688 1.812 2.317 1.455 2.012 1.917 814 2.149 1.045 1.504 1.303 803 2.557
2026/2027941 920 21 0 0 0 0 0 0 0 0 0 0
Totale 65.765